Status:
UNKNOWN
Tumescent Lidocaine Maximum Safe mg/kg Dosage
Lead Sponsor:
Klein, Jeffrey A., M.D.
Conditions:
Anesthesia
Eligibility:
FEMALE
18-72 years
Phase:
PHASE1
PHASE2
Brief Summary
This pharmacokinetic clinical trial is a dose ranging study of lidocaine in tumescent local anesthesia. The goal is to understand the absorption pharmacokinetic of tumescent lidocaine and to determine...
Detailed Description
Background: Tumescent local anesthesia (TLA) permits a wide variety of therapeutic surgical procedures of subcutaneous tissues and skin to be performed totally by local anesthesia ( ). Infiltration o...
Eligibility Criteria
Inclusion
- Healthy female (ASA class 1 or 2)
- Desires liposuction
- Easily accessible veins
Exclusion
- History of Hepatitis C, HIV
- ASA class greater or equal to 3
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2011
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00977028
Start Date
January 1 2005
End Date
August 1 2011
Last Update
June 16 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Capistrano Surgery Center
San Juan Capistrano, California, United States, 92675